Global Fluorescent Protein Labeling Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Fluorescent Protein Labeling Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Fluorescent proteins are members of a structurally homologous class of proteins that share the unique property of being self-sufficient to form a visible wavelength chromophore from a sequence of 3 amino acids within their own polypeptide sequence. Fluorescent protein labeling refers to a method that uses fluorescent plasmids of different colors to combine with other organisms in a certain way, and finally carries color fluorescence without affecting the normal physiological growth of organisms.

Market Overview:

The latest research study on the global Fluorescent Protein Labeling market finds that the global Fluorescent Protein Labeling market reached a value of USD 378.45 million in 2022. It’s expected that the market will achieve USD 622.14 million by 2028, exhibiting a CAGR of 8.64% during the forecast period.

Since 2020, the global outbreak of the new crown pneumonia epidemic. The government has taken measures such as suspension of work, restrictions on population movement, and isolation of relevant personnel for prevention and control, which may have a certain impact on the normal production and operation of Fluorescent Protein Labeling enterprises. The normal production and operation of some downstream customers of Fluorescent Protein Labeling, including scientific research institutes and pharmaceutical R&D units, will be affected to a certain extent.

At the same time, the biopharmaceutical industry has a rapidly growing demand for raw materials for anti-coronavirus drugs, proteins for vaccine research and development, and diagnostic reagents. Countries have enhanced awareness of prevention and control and attached importance to scientific research in biomedicine and the development and production of corresponding diagnostic reagents, therapeutic drugs and vaccines, which is conducive to the development of the Fluorescent Protein Labeling market.

Advances in life science basic research and biotechnology drive the Fluorescent Protein Labeling market

With the deepening of basic research in life sciences, especially the continuous breakthroughs in basic disciplines such as genomics, proteomics, molecular biology, cell biology, and immunology, the pathogenesis of tumors, autoimmune diseases, cardiovascular diseases and other diseases has been greatly improved. Research has gradually become clear, and more and more druggable targets have been discovered, making it possible to develop more biological drugs. At the same time, the continuous progress of biotechnologies such as synthetic biology, gene sequencing and editing has also promoted the rapid development of emerging therapeutic technologies such as monoclonal antibody drugs, bispecific antibodies, antibody-drug conjugates (ADC), and cellular immunotherapy, becoming biopharmaceuticals Development direction of R&D. Fluorescent Protein Labeling is an indispensable biological reagent for the development and production of biological drugs, and the market demand is gradually expanding. In the future, the Fluorescent Protein Labeling market will enter into a more rapid development.

Capital continues to help the biopharmaceutical industry and promote the development of the Fluorescent Protein Labeling market

Targeted therapy, immunotherapy and cell therapy have gradually emerged to become mainstream, significantly improving the therapeutic effect of tumors, autoimmune diseases and other diseases, and meeting the huge demand for clinical treatment. Antibody drugs and cellular immunotherapy have played a pivotal role in targeted therapy, immunotherapy and cell therapy, and have become the focus of capital. The injection of capital has promoted the research and development and production of antibody drugs and cellular immunotherapy. At the same time, since the research and development and production of antibody drugs and cellular immunotherapy require Fluorescent Protein Labeling, capital's attention to the biopharmaceutical industry has further promoted the development of the Fluorescent Protein Labeling market.

Region Overview:

From 2022-2027, North America is estimated to witness robust growth prospects

Company Overview:

Thermo Fisher (Life Technologies) is one of the major players operating in the Fluorescent Protein Labeling market, holding a share of 27.5% in 2022.

Thermo Fisher (Life Technologies)

Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services. Life Technologies was acquired by Thermo Fisher Scientific in January, 2014.
Product areas: Analytical Instruments, Laboratory Supply Chain Programs and eCommerce, Laboratory Equipment, Lab Services, Specialty Diagnostics, Life Sciences, Pharma Services, and CDMO

BD Biosciences

BD is a global medical technology company that provides flow cytometers, reagents, tools, and a wide range of services.
Product areas: Medical Devices, Biosciences, Medical Supplies, Laboratory Instruments, Reagents, Diagnostics Products, Antibodies, Surgical, and Vascular Access

Segmentation Overview:

Among different product types, Labeling 20 to 100 μg protein segment is anticipated to contribute the largest market share in 2027.

Labeling 1 to 10 mg of protein

Labeling 1 to 10 mg of protein Introduction type products are suitable for relatively large-scale scientific experiments. In addition, labeling a higher number of proteins also contributes to the accuracy of the data results. More suitable for molecular weights between 20-150kDa. kDa (kilodalton) is a unit of mass that equal to 1000 DALTONS.

Labeling 20 to 100 μg protein

Labeling 20 to 100 μg protein products are suitable for relatively small-scale scientific experiments. More suitable for molecular weights between 12-150kDa.

Application Overview:

The market's largest segment by application is the segment Biopharmaceutical Manufacturers, with a market share of 43.29% in 2021.

Key Companies in the global Fluorescent Protein Labeling market covered in Chapter 3:

AnaSpec
Thermo Fisher (Life Technologies)
AAT Bioquest
BD Biosciences
Merck Millipore
Bio-Rad Laboratories
PerkinElmer (BioLegend)
Miltenyi Biotec
Biotium

In Chapter 4 and Chapter 14.2, on the basis of types, the Fluorescent Protein Labeling market from 2018 to 2029 is primarily split into:

Labeling 1 to 10 mg of protein
Labeling 20 to 100 μg protein
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Fluorescent Protein Labeling market from 2018 to 2029 covers:

University and Research Institutions
Biopharmaceutical Manufacturers
Hospital and Commercial Laboratories
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)